SCHEMBL13348929

SCHEMBL13348929

Nc1ccc(-c2cn(-c3cc4cc5c6c(c4oc3=O)CCCN6CCC5)nn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC16A3 O15427 1/20 0.49
▸ USP2 O75604 7/20 0.47
▸ MEN1 O00255 6/20 0.47
▸ KMT2A Q03164 6/20 0.47
▸ ALDH1A1 P00352 6/20 0.47
▸ GAA P10253 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ MAPT P10636 4/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ RECQL P46063 3/20 0.47
▸ TLR9 Q9NR96 1/20 0.47
▸ CASP1 P29466 5/20 0.47
▸ CASP7 P55210 5/20 0.47
▸ BRCA1 P38398 2/20 0.47
▸ HBB P68871 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ ALOX15 P16050 4/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13315803 0.91 SLC16A3 (0.53) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13315806 0.85 USP2 (0.47) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13315804 0.85 SLC16A3 (0.44) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13315809 0.76 HDAC3 (0.45) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL14311186 0.71 SLC16A3 (0.62) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13050804 0.70 SLC16A3 (0.70) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL15398217 0.69 USP2 (0.64) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL4309506 0.69 USP2 (0.61) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL28109948 0.69 SLC16A3 (0.73) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13486876 0.69 SLC16A3 (0.69) SLC16A3USP2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152431-A1 COMPOSITIONS, PROBES AND CONJUGATES AND USES THEREOF THIRD WAVE TECHNOLOGIES, INC. (US) 2010-06-17 — — US disclosed
US-7674924-B2 Compositions, probes, and conjugates and uses thereof THIRD WAVE TECHNOLOGIES, INC. (US) 2010-03-09 — — US disclosed
US-20080071074-A1 Compositions, probes, and conjugates and uses thereof THIRD WAVE TECHNOLOGIES, INC. (US) 2008-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152431-A1 COMPOSITIONS, PROBES AND CONJUGATES AND USES THEREOF ALKBH1, DUT, NT5E SLC16A3 4047/4885USP2 3145/4885MEN1 3420/4885
US-20080071074-A1 Compositions, probes, and conjugates and uses thereof ALKBH1, ALK, DUT SLC16A3 4132/4885USP2 3167/4885MEN1 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback